Related Experiment Video
Updated: Feb 15, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma
Fan Feng1, Qiyu Jiang2, Shuang Cao3
1Center for Clinical Laboratory, The 302nd Hospital of Chinese PLA, Beijing 100039, PR China; Liver Failure Treatment and Research Center, The 302nd Hospital of Chinese PLA, Beijing 100039, PR China.
Background:
Kinase inhibitor sorafenib is the most widely used drug for advanced HCC clinical treatment nowadays. However, sorafenib administration is only effective for a small portion of HCC patients, and the majority develop sorafenib-resistance during treatment. Thus, it is urgent to discover the endogenous mechanism and identify new pharmaceutical targets of sorafenib-resistance.
Methods:
Pregnane X receptor (PXR) was detected by immunohistochemistry and quantitative PCR. GST-pull down and LC-MS/MS was used to detect the interaction of PXR and Sorafenib. To test the properties of HCC tumor growth and metastasis, in vivo tumor explant model, FACS, trans-well assay, cell-survival inhibitory assay and Western blot were performed. In terms of mechanistic study, additional assays such as ChIP and luciferase reporter gene assay were applied.
Results:
In the present work, we found high PXR level in clinical specimens is related to the poor prognosis of Sorafenib treated patients. By the mechanistic studies, we show that sorafenib binds to PXR and activates PXR pathway, and by which HCC cells develop sorafenib-resistance via activating. Moreover, PXR overexpression helps HCC cells to persist to sorafenib treatment.
Conclusion:
This study reports the endogenous sorafenib-resistance mechanism in HCC cells, which offers an opportunity to design new therapeutic approaches for HCC treatment.
General Significance:
PXR mediates sorafenib-resistance in HCC cells and targeting PXR can be a useful approach to facilitate HCC treatment.
Insights
High pregnane X receptor (PXR) levels drive sorafenib resistance in liver cancer (HCC) cells. Targeting PXR offers a new therapeutic strategy to improve sorafenib treatment efficacy for HCC patients.
Area of Science:
- Hepatocellular Carcinoma (HCC) Research
- Drug Resistance Mechanisms
- Molecular Oncology
Background:
- Sorafenib is a primary treatment for advanced HCC, but its effectiveness is limited by widespread drug resistance.
- Identifying the endogenous mechanisms of sorafenib resistance is crucial for developing better therapeutic strategies.
Purpose of the Study:
- To investigate the role of Pregnane X receptor (PXR) in mediating sorafenib resistance in HCC.
- To explore PXR as a potential therapeutic target for overcoming sorafenib resistance.
Main Methods:
- Detected PXR levels using immunohistochemistry and qPCR.
- Assessed PXR-sorafenib interaction via GST-pull down and LC-MS/MS.
- Evaluated HCC tumor growth, metastasis, and cell survival using in vivo models, FACS, trans-well assays, and Western blot.
- Investigated mechanisms using ChIP and luciferase reporter assays.
Main Results:
- High PXR levels in clinical HCC specimens correlate with poor prognosis in patients treated with sorafenib.
- Sorafenib binds to and activates PXR, leading to the development of sorafenib resistance in HCC cells.
- PXR overexpression enhances HCC cell survival during sorafenib treatment.
Conclusions:
- PXR plays a key role in mediating sorafenib resistance in HCC.
- Targeting PXR presents a promising therapeutic approach to enhance HCC treatment outcomes.
Related Concept Videos
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Internal Receptors
Resistivity
Resistance
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.

